BIBLIOGRAFIA
1. Jemal A., Siegel R., Ward E HY, Xu J., Murray T., M.J. T. Cancer statistics, 2008.
CA Cancer J 2. Clin 2008; 58:71-96.
2. Documento tecnico di indirizzo per ridurre il carico di malattia del cancro per il 2011- 2013, Ministero della Salute
3. An interactive tool for access to SEER cancer statistics. Surveillance Research Program. ,National CancerInstitute.
4. FIGO committee on Gynaecologic Oncology. Int J Gynaecol Obstet 2009; 105:
5. Soliman PT, Oh JC, Schmeler KM et al. Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol 2005; 105: 575–580
6. Bokhman JV, Chepick OF, Volkova AT, Vishnevsky AS. Adjuvant hormone therapy of primary endometrial carcinoma with oxyprogesterone caproate. Gynecol Oncol 1981; 11: 371–78.
7. DiSaia PJ, Creasman WT, Boronow RC, Blessing JA. Risk factors and recurrent patterns in Stage I endometrial cancer. Am J Obstet Gynecol 1985; 151: 1009–15 8. .Rose PG. Endometrial carcinoma. N Engl J Med 1996; 335: 640–649.
9. Bokhman JV, Chepick OF, Volkova AT, Vishnevsky AS. Adjuvant hormone therapy of primary endometrial carcinoma with oxyprogesterone caproate. Gynecol Oncol 1981; 11: 371–78. DiSaia PJ, Creasman WT, Boronow RC, Blessing JA. Risk factors and recurrent patterns in Stage I endometrial cancer. Am J Obstet Gynecol 1985; 151:
1009–15.
10. hepherd JH: Revised FIGO staging for gynecological cancer. BJOG 1989;96(8):889- 92
11. Jobsen JJ et al.: Multicentric cohort study on treatment results and risk factors in stage II endometrial carcinoma. Int J Gynecol Cancer 2008;18:1071-78 5
12. Zaino RJ.: FIGO staging of endometrial adenocarcinoma: a critical review and proposal. Int J Gynecol Pathol 2009;28(1):1-9 5-bis.
13. Tebeu PM et al.:Positive peritoneal cytology in early stage endometrial cancer does not influence prognosis. Br J Cancer 2004;19:720-4
14. PecorelliS.: Revised FIGO staging for carcinoma of the vulva, cervix and endometrium. Int J Gynecol Obstet 2009;105(2):103-104.
15. Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, Benedet JL, Heintz AP, Ngan HY, Pecorelli S. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov;95
16. ACOG Practice Bulletin. Clinical management guidelines for obstetricians- gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol 2005;106:413-425
17. Mariani A et al.: Low risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 2000;182(6):1506-1519Trimble EL et al.: Lumph node sampling and survival in endometrial cancer Gynecol Oncol 1998;71(3):340-3 18. Chi DS et al.: The incidence of pelvic lymph node metastasis by FIGO staging for
patients with adequate surgically staged endometrial adenocarcinoma of endometrioid histology.Int J Gynecol Cancer2008;18(2):269:273
19. BenShachar Ietal.: Surgical staging for patients presenting with grade 1 endometrial carcinoma. Obstet Gynecol 2005;105(3):487-493.
20. Frumovitz M et al.: Predictors of final histology in patients with endometrial cancer.
Gynecol Oncol 2004;463
21. Montalto SA et al.: Accuracy of frozen section diagnosis at surgery in pre malignant and malignant lesions of the endometrium. Eur J Gynaecol Oncol 2008;29(5):435-4
22. Cho H et al.: Accuracy of preoperative tests in clinical stage I endometrial cancer: the importance of lymphadenectomy. Acta Obstet Gynecol Scand 2010;89(2):175-81 23. Creutzberg CL et al.: Surgery and postoperative radiotherapy versus surgery alone for
patients with stage-1 endometrial carcinoma: multicentre randomized trial. PORTEC Study Group. Post Operative Radiation Therapy In Endometrial Carcinoma. Lancet 2000;355:1404-1411
24. Keys HM et al.: A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004;92:744-751
25. Panici PB et al.: Systematic pelvic lymphadenectomy vs no lymphadenectomyin early stage endometrial carcinoma. J NCI 2008;100(23):1707-1
26. Walsh C. et al.: Lymphadenectomy’s role in early endometrial cancer: prognostic or therapeutic? JNCI 2008;100(23):1660-6
27. Hidaka T et al.: Systemic lymphadenectomy cannot be recommended for low-risk corpus cancer. Obstet Gynecol Int 2010;doi:10.1155/2010/49021
28. Chan JK et al.: Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12333 patients. Cancer 2006;107(8):1823-30
29. May K et al.Lymphadenectomyfor the management of endometrial cancer (review).
The Cochrane Library 2010;1:1-45
30. Kitchener HCetal.: Efficacy of systemic lymphadenectomy in endometrial cancer (MRC ASTEC Trial): a randomized study. Lancet 2009;373(9658):125-136ee
31. TS et al.: Benefit off lymphadenectomy in endometrial cancer: can the truth be obtained by randomized controlled trial after ASTEC?. Int J Gynecol Cancer 2009;19(8):146
32. Gynecologic Oncology Group, Surgical Manual, July 25, 2005;p 11-12
33. Toda Y et al.: Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 2010;DOI:10.1016/S0140- 6736(09)62002-x
34. Dargent D: Laparoscopic surgery and gyneco- logic cancer. Curr Opin Obstet Gynecol 5:294-300, 1993
35. Querleu D, Leblanc E, Castelain B: Laparo- scopic pelvic lymphadenectomy in the staging of early carcinoma of the cervix. Am J Obstet Gynecol 164:579-581, 1991 36. Childers JM, Spirtos NM, Brainard P, et al: Laparoscopic staging of the patient with
incom- pletely staged early adenocarcinoma of the endome- trium. Obstet Gynecol 83:597-600, 1994
37. Spirtos NM, Schlaerth JB, Spirtos T Zorlu CG, Simsek T, Ari ES. Laparoscopy or laparotomy for the man- agement of endometrial cancer. JSLS. 2005;9:442–446.
38. Kalogiannidis I, Lambrechts S, Amant F, Neven P, van Gorp T, Vergote I.
Laparoscopy-assisted vaginal hysterectomy compared with abdominal hysterectomy in clinical stage I endometrial cancer: safety, recurrence, and long term outcome. Am J Obstet Gynecol. 2007;196:248.e1–248.e8.
39. Obermair A, Manolitsas TP, Leung Y, Hammond IG, McCartney AJ. Total laparoscopic hysterectomy for endometrial cancer: patterns of re-currence and survival. Gynecol Oncol. 2004;92:789–793
40. Nezhat F, Yadav J, Rahaman J, Gretz H, Cohen C. Analysis of serviva after laparoscopic management of endometrial cancer. J Minim Invasive Gynecol.
2008;15:181–187.
41. Zullo F, Palomba S, Russo T, et al. A prospective randomized compar- ison between laparoscopic and laparotomic approaches in women with early stage endometrial cancer: a focus on the quality of life. Am J Ob- stet Gynecol. 2005;193:1344–1352.
42. Magrina J, Mariani A, Magtibay P. Laparoscopy for endometrial cancer. In: Nezhat C, Nezhat F, Nezhat C, editors. Nezhat’s Operative Gyneco- logic Laparoscopy and Hysteroscopy. 3rd ed. New York: Cambridge University Press; 2008. p. 465–474.
43. Walker JL, Piedmonte MR, Spirtos NM, et al. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine can- cer: Gynecologic Oncology Group study LAP2. J Clin Oncol 2009;27:5331-6.
44. Walker JL, Piedmonte MR, Spirtos NM, et al. Recurrence and survival after random assignment to laparoscopy versus laparotomy for compre- hensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study. J Clin Oncol.
2012;30:695–700.
45. Bell MC, Torgerson J, Seshadri-Kreaden U, Suttle AW, Hunt S. Comparison of outcomes and cost for endometrial cancer staging via traditional laparotomy, standard laparoscopy and robotic techniques. Gynecologic Oncology 2008;111(3): 407–11.
46. Boggess 2008a {published data only} Boggess JF, Gehrig PA, Cantrell L, Shafer A, Ridgway M,
47. Skinner EN, et al.A case-control study of robot-assisted type III radical hysterectomy with pelvic lymph node dissection compared with open radical hysterectomy.
American Journal of Obstetrics and Gynecology 2008;199(4):357.e1–7.
48. Boggess Boggess JF, Gehrig PA, Cantrell L, Shafer A, Ridgway M, Skinner EN, et al.A comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: robotic assistance, laparoscopy, laparotomy. American Journal of Obstetrics and Gynecology 2008;199(4):360.e1–9.
49. Cardenas-Goicoechea Cardenas-Goicoechea J, Adams S, Bhat SB, Randall TC.
Surgical outcomes of robotic-assisted surgical staging for endometrial cancer are equivalent to traditional laparoscopic staging at a minimally invasive surgical center.
Gynecologic Oncology 2010;117(2):224–8. [PUBMED: 20144471]
50. DeNardis DeNardis SA, Holloway RW, Bigsby GE 4th, Pikaart DP, Ahmad S, Finkler NJ. Robotically assisted laparoscopic hysterectomy versus total abdominal hysterectomy and lymphadenectomy for endometrial cancer. Gynecologic Oncology 2008;111(3):412–7. [PUBMED: 18834620] Gehrig PA, Cantrell LA, Shafer A, Abaid LN, Mendivil A, Boggess JF. What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman?.
Gynecologic Oncology 2008;111 (1):41–5.
51. Hoekstra AV, Jairam-Thodla A, Rademaker A, Singh DK, Buttin BM, Lurain JR, et al.The impact of robotics on practice management of endometrial cancer: transitioning from traditional surgery. The International Journal of Medical Robotics and Computer Assisted Surgery 2009;5(4): 392–7. [PUBMED: 19455550] amon 2009a {published data only} Seamon LG, Cohn DE, Henretta MS, Kim KH, Carlson MJ, Phillips GS, et al.Minimally invasive comprehensive surgical staging for endometrial cancer:
Robotics or laparoscopy?. Gynecologic Oncology 2009;113(1):36–41. [PUBMED:
19168206]
52. Seamon 2009b {published data only} Seamon LG, Bryant SA, Rheaume PS, Kimball KJ, Huh WK, Fowler JM, et al.Comprehensive surgical staging for endometrial cancer in obese patients: comparing robotics and laparotomy. Obstetrics and Gynecology 2009;114(1): 16–21.
53. DongHao Lu1, Zhihong Liu2, Gang Shi1, Dan Liu3, Xiaoyan Zhou 2012 Robotic assisted surgery for gynaecological cancer The Cochrane Collaboration Amant F, Moerman P, Neven P et al .Endometrial cancer. Lancet 2005; 366:491-505
54. Kuroki J, Hasegawa K, Kato R, Mizukawa J et al. Relationship between the classification of vascular invasion severity and the prognosis of uterineendometrial cancer. Int J Gynecol Cancer 2003, 13, 47—52
55. Saffari B, Benstein L, Hong DC, Sullivan Halley J, Runnebaum IB, Grill HJ, Jones LA, El-Naggar A, PressMF. Association of p53 mutations and a codon 72 single nucleotide polymorphism with lower overall survival and responsiveness to adjuvant radiotherapy in endometrioid endometrial carcinomas. Int J Gynecol Cancer 2005, 15, 952–963
56. Creutzberg CL, van Putten WL, Warlam-Rodenhuis CC, van de Bergh AC, de Winter KA, Koper PC, Lybeert ML et al. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: postoperative radiation therapy in endometrial carcinoma trial. J Clin Oncol. 2004;22:1234-41
57. Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Warlam- Rodenhuis CC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomized trial. Lancet.
2000;355:1404-11
58. Keys HM, Roberts AJ, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, Pearlman A, Maiman MA, Bell JG. A phase III trial of surgery with or without adjunctive external pelvic radiatio therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004;92:744-51
59. Mangili G, De Marzi P,Viganò R, Rabaiotti E, Sassi I, Taccagni GL, Garancini P, Frigerio L. Identification of high risk patients with endometrial carcinoma. Prognostic assessment of endometrial cancer. Eur J Gynaecol Oncol. 2002;23(3):216-20
60. Morice P. Levy-Piedbois C, Ajaj S, et al. Value and cost evaluation of routin follow- up for patients with clinical stag I/II endometrial cancer. Eur J Cancer 2001;37:895- 90.
61. Owen P,Duncan ID.Is it any value in the long term follow up of women treated for endometrial cancer?BR J Obstet Gynecol 1996;103:710-3.
62. Berchuck A,Anspach C, Evans AC,Soper JT,Rodriguez GC, Dodge R et al.Postsurgical surveillance of patients with FIGO stage I-II endometrial adenocarcinoma.Gynecol Oncol 1995;59:20-4.
63. Gadducci A,Cosio S, Fanucchi A,Cristofani R,Genazzani AR.An intensive follow up does not change survival of patients with clinical stage I endometrial cancer.anticancer Res 2000;20:1977-84.
64. Agboola OO,Grunfeld E,Coyle D,Perry GA.Cost and benefits of routine follow up after curative treatment for endometrial cancer.CMAJ 1997;157:879-86.
65. Gordon AF,Owen P,Chien PFW,Duncan ID.A critical evaluation of follow up of women treated for endometrial adenocarcinoma.J Obstet Gynecol 1997;17:386-9.
66. Ng TY,Ngan HYS,Cheng DKL,Wong LC.Vaginal vault cytology in the routine follow up of patients treated for endometrial carcinoma:is it useful?Aust NZ J Obstet Gynecol 1997;37:104-6.
67. Salvesen HB,Akslen LA,Irvesen T,Irvesen OE.Recurrence of endometrial carcinoma and the valueof routine follow up.Br J Obstet Gynecol 1997;104:1302-7.
68. Reddoch JM,Burke TW,Morris M,Tornos C,Levenback C,Gersheson DM.Surveillance for recurrent endometrial carcinoma: developement of a follow up scheme.Gynecol Oncol 1995;59:221-5.
69. Shumsky AG,Stuart GC,Brasher PM,Nation JG,Robertson DI,Sangkarat S.An evaluation of routine follow up of patients treated for endometrial carcinoma.Gynecol Oncol 1994;55:229-33.
70. Podczasky E,Kaminsky P,Gurski K,MacNeill C,Stryker JA,Singapuri K et al.Detection and patterns of treatment failure in 300 consecutive cases of “early”
endometrial cancer after primary surgery.Gynecol Oncol 1992;47:323-7.
71. MacDonald JH,Kidd GM.An audit of endometrial carcinoma: the value of routine
72. Patsner B,Orr Jr Jw,Mann Jr WJ.Use of serum CA125 measurement in post-treatment surveillance of early stage endometrial carcinoma.Am J Obstet Gynecol 1990;162:427-9.
73. Rose PG,Sommers RM,Reale FR,Hunter RE,Fournier L,Nelson BE.Serial serum CA125 measurements for evaluation of recurrence in patients with endometrial carcinoma.Obstet Gynecol 1994;84:12-6.
74. Lo SS,Khoo US,Cheng DK,Ng TY,Wong LC,Ngan HY.Role of serial tumor markers in the surveillance foe recurrence in endometrial cancer.Cancer Detect Prev 1999;23:397-00.
75. Price FV,Chambers SK,Carcangiu ML,Kohorn EI;Schwartz PE,Chambers JT.CA125 may not reflect disease status in patients with uterine serous carcinoma.Cancer 1998;82:1720_5.
76. Kew FM,Roberts AP, Cruickshank DJ.The role of routine follow up after gynecological malignancy.Int J Gynecol Cancer 2005;15:413-9.
77. Tjalma WA,van Dam PA,Makar AP,Cruickshank DJ.The clinical value and cost- effectiveness of follow up in endometrial cancer patients.Int J Gynecol Cancer 2004;14:931-
78. E.Sartori, B.Pasinetti L.Carrara, A.Gambino, F.Odicino, S.Pecorelli. Pattern of failure and value of follow up procdures in endometrial and cervical cancer patients.
79. Lim PC, Kang E, Park do H. A comparative detail analysis of the learning curve &&
and surgical outcome for robotic hysterectomy with lymphadenectomy versus laparoscopic hysterectomy with lymphadenectomy in treatment of endometrial cancer:
a case-matched controlled study of the first one hundred twenty two patients. Gynecol Oncol 2011; 120:413 – 418
80. Holloway RW, Ahmad S, DeNardis SA, et al. Robotic-assisted laparoscopic hysterectomy and lymphadenectomy for endometrial cancer: analysis off surgical performance. Gynecol Oncol 281)009;115:447 – 452.
81. Robinson BL, Liao JB, Adams SF, et al. Vaginal cuff dehiscence after robotic total lapa- roscopic hysterectomy. Obstet Gynecol 2009;114(Pt 1):369-71.
82. Abu-Rustum NR, Alektiar K, Iasonos A, Lev G, Sonoda Y, Aghajanian C, et al. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol 2006;103:714–8.
83. Todo Y, Yamamoto R, Minobe S, Suzuki Y, Takeshi U, Nakatani M, et al. Risk factors for postoperative lower-extremity lymphedema in endometrial cancer survivors who had treatment including lymphadenectomy. Gynecol Oncol 2010;119:60–4.
84. Todo Y, Kato H, Okamoto K, Minobe S, Suzuki Y, Ohba Y, et al. Incidence of metas- tasis in circumflex iliac nodes distal to the external iliac nodes in intermediate- and high-risk endometrial cancer. Gynecol Oncol 2011;122:55–8.
85. Lajer H, Widecrantz S, Hernias in trocar ports following abdominal laparoscopy. A review. Acta Obstet Gynecol Scand 1997;76:389–93.
86. Mac Cordick C, Le ́curu F, Rizk E, Robin F, Boucaya V, Taurelle R.. Morbidity in laparoscopic gynecologic surgery: results of a prospective single-center study. Surg Endosc 1999; 57–61.
87. Eltabbakh GH. Small bowel obstruction secondary to hernia- tion through a 5-mm laparoscopic trocar site following laparo- scopic lymphadenectomy. Eur J Gynaecol Oncol 1999;20: 275–6.
88. Tonouchi H, Ohmori Y, Kobayashi M, Kusunoki M. Trocar site hernia. Arch Surg 2004;139:1248–56
89. Li TC, Saravelos H, Richmond M, Cooke ID. Complications of laparoscopic pelvic surgery: recognition, management and prevention. Hum Reprod Update 1997;3:505–1
90. Montz FJ, Holschneider CH, Munro MG. Incision hernia following laparoscopy: a survey of the American Association of Gynecologic Laparoscopists. Obstet Gynecol 1994;84:881–4
91. Kadar N, Reich H, Liu CY, Manko GF, Gimpelson R. Incisional hernia after major laparoscopic gynecologic proce- dures. Am J Obstet Gynecol 1993;168:1493–5.
92. NezhatC,NezhatF,SeidmanDS,NezhatC.Incisionalhernias after operative laparoscopy.
J Laparoendosc Adv Surg Tech A 1997;7:111–5.
93. Magrina JF, Zanagnolo V, Giles D, Noble BN, Kho RM, Magtibay PM. Robotic surgery for endometrial cancer: comparison of perioperative outcomes and recurrence with laparoscopy, vaginal/laparoscopy and laparotomy. Eur J Gynaecol Oncol.
2011;32(5):476-80.
94. Fader AN, Seamon LG, Escobar PF, Frasure HE, Havrilesky LA, Zanotti KM, Secord AA, Boggess JF, Cohn DE, Fowler JM, Skafianos G, Rossi E, Gehrig PA. Minimally invasive surgery versus laparotomy in women with high grade endometrial cancer: A multi-site study performed at high volume cancer centers. Gynecol Oncol. 2012 Aug;126(2):180-5. Epub 2012 Apr 30.
